Basilea Pharmaceutica Logo

Basilea Pharmaceutica

🇨🇭
BSLN
CH0011432447

Basilea Pharmaceutica is a Swiss-based biopharmaceutical company specializing in the development of innovative medicines. Its primary focus is addressing resistant bacterial and fungal infections, as well as advancing oncology through the creation of targeted therapeutic solutions.

Next Quarterly Earnings

Tuesday, August 18, 2026
CW 34
Pre-Market
In 37 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on July 21, 2026

Stock Price

Frequently asked questions

When will Basilea Pharmaceutica report its next quarterly earnings?

Basilea Pharmaceutica is scheduled to report its next quarterly earnings on 08/18/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Basilea Pharmaceutica last report quarterly earnings?

Basilea Pharmaceutica last reported quarterly earnings on 2/17/2026 (Q1 2026). Earnings per share (EPS) came in at 3.14 CHF.

How do I add the Basilea Pharmaceutica earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:CHF 3.34
Actual:
Q1 2026
Estimate:
Actual:CHF 3.14

Company Information

Name
Basilea Pharmaceutica
Ticker Symbol
BSLN
ISIN
CH0011432447
Country
🇨🇭
Switzerland
Sector
Healthcare